$9.94
+2.1%Varex Imaging Corporation designs and manufactures X-ray imaging components. The company operates in two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components comprising X-ray tubes, digital detectors, high voltage connectors, image-processing software and workstations, 3D reconstruction and computer-aided diagnostic software, collimators, automatic exposure control devices, generators, heat exchangers, ionization chambers, and buckys. This segment's products are used in a range of applications, including radiographic and fluoroscopic imaging, mammography, computed tomography, radiation therapy, oncology, CT, cardiac, surgery, dental, computer-aided detection, and other diagnostic radiography uses. The Industrial segment designs, manufactures, sells, and services Linatron X-ray accelerators, X-ray tubes, digital detectors, and high voltage connectors for use in security and industrial inspection applications, such as airport security, cargo screening at ports and borders, and nondestructive testing and examination in various applications. Varex Imaging Corporation sells its products through imaging system original equipment manufacturers, independent service companies, and distributors, as well as directly to end-users. The company has operations in North America, South America, Europe, Russia, the Middle East, India, Africa, Asia, and Australia. Varex Imaging Corporation was founded in 2016 and is based in Salt Lake City, Utah.
Chief Financial Officer & Principal Accounting Officer
Compensation
$607,495
Chief Human Resources Officer
Compensation
$450,175
Chief Legal Officer, General Counsel & Corporate Secretary
Compensation
$493,904
Director of Investor Relations
President, Chief Executive Officer & Director
Compensation
$999,495
Senior Vice President & GM of X-Ray Sources
Compensation
$532,893
Senior Vice President & GM of X-ray Detectors
Compensation
$484,174
Vice President & MD for China
During the last 12 months, insiders have sold $141K worth of VREX shares, with no buying activity reported.
0
0.00
4.5K
50.24K
-50K
-$50K
0
0.00
0
0.00
+0
+$0
0
0.00
3.2K
39.17K
-39K
-$39K
0
0.00
5.6K
51.48K
-51K
-$51K
No buying activity
Kunkel Jay K.
Director
$102K
Aranki Karen L
Officer: Chief Human Resources Officer
$39K
Strong bearish signal with $141K net selling. Heavy insider selling may indicate concerns about valuation or near-term prospects.
Very poor ratio. Heavy selling with minimal buying suggests insiders may be concerned about valuation or outlook.
Heavy recent selling activity. Recent insider sales notably exceed purchases—may warrant investigation into company developments.
2 insider sellers vs. 0 buyers. Widespread selling across multiple insiders may signal concerns.
Persistent selling pressure: Consistent insider selling with weak buy/sell ratio suggests insiders may be capitalizing on current valuation. Exercise caution and review recent earnings quality and management commentary.
VREX - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
DEF 14A DEF 14A 2026 N/A | December 29, 2025 | February 12, 2026 | 2026 | |
DEF 14A DEF 14A 2025 N/A | December 30, 2024 | February 13, 2025 | 2025 | |
DEF 14A DEF 14A 2024 N/A | December 27, 2023 | February 08, 2024 | 2024 | |
DEF 14A DEF 14A 2023 N/A | December 28, 2022 | February 09, 2023 | 2023 | |
DEF 14A DEF 14A 2022 N/A | December 28, 2021 | February 10, 2022 | 2022 | |
DEF 14A DEF 14A 2021 N/A | December 30, 2020 | February 11, 2021 | 2021 | |
DEF 14A DEF 14A 2020 N/A | January 02, 2020 | February 13, 2020 | 2020 | |
DEF 14A DEF 14A 2019 N/A | January 02, 2019 | February 14, 2019 | 2019 | |
DEF 14A DEF 14A 2018 N/A | January 03, 2018 | February 15, 2018 | 2018 |
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.